IFNA1 and secondary progressive multiple sclerosis: The relation between expression of IFN inducible genes and clinical response to treatment, as observed in RRMS patients, suggests that in SPMS patients as well, the ability of inflammatory blood cells to have a transcriptional response to IFN, as we observed in 60 % of patients, is a necessary prerequisite for clinical response.